- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 151
Working Capital lands funding from Zalando
Zalando and Childrens Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.
Sep 23, 2018Medtronic marks Mazor for acquisition
Technion’s robotic surgery business Mazor Robotics has been snapped up by medical device developer Medtronic, which had already invested $72m in the company.
Sep 21, 2018Amicus captures Celenex
Nationwide Children’s Hospital spinout Celenex could fetch as much as $452m upon completion of milestones after progressing rare disease therapies conceived at the hospital’s collaborative program with Ohio State University.
Sep 20, 2018Infosys sucks up Fluido in $76m acquisition
Salesforce Ventures is set to exit CRM services provider Fluido three years after backing a $3.5m round, in an acquisition by Infosys.
Sep 20, 2018Boehringer Ingelheim greets ViraTherapeutics in $245m purchase
Cancer drug developer ViraTherapeutics has been acquired by Boehringer Ingelheim, three years after the corporate led its series A round.
Sep 14, 2018WeWork gets a new Teem in $100m deal
GE Ventures and NGP Capital have exited workplace software provider Teem in a $100m acquisition by WeWork.
Sep 14, 2018NetGear draws up Meural acquisition
Electronic art frame producer Meural has been acquired by NetGear less than a year after the corporate took part in its series A round.
Sep 13, 2018Intel catches NetSpeed in acquisition deal
Network-on-chip technology developer NetSpeed has been acquired by Intel, an investor in the company since 2014, for an undisclosed amount.
Sep 13, 2018Chain tethers to Lightyear to go Interstellar
Chain, a blockchain technology provider backed by Visa, Orange, Fiserv, Nasdaq, Citi and Capital One, has merged with Lightyear to form a new company dubbed Interstellar.
Sep 12, 2018Augmenix gels with Boston Scientific for $600m
Boston Scientific will pay $500m upfront and up to $100m in milestone payments to acquire Augmenix, providing exits to Varian Medical Systems and Ascension Health.
Sep 10, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


